News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Apply for the EACR-Mark Foundation-Pezcoller Foundation Rising Star Award 2025
Collage photo of EACR, Mark Foundation and Pezcoller Foundation
Sep 1, 2024, 14:58

Apply for the EACR-Mark Foundation-Pezcoller Foundation Rising Star Award 2025

European Association for Cancer Research (EACR) shared a post on LinkedIn:

“Do you have an unfunded Score ‘A’ cancer-related project from the 2024 ERC Starting Grant calls?

Apply for the EACR-Mark Foundation-Pezcoller Foundation Rising Star Award 2025!

All the info you need here.”

Proceed to the video attached to the post.
Source: EACR/LinkedIn

2024 ERC Starting Grant calls cancer EACR EACR-Mark Foundation-Pezcoller Foundation Rising Star Award 2025 European Association for Cancer Research Mark Foundation OncoDaily Oncology Pezcoller Foundation
Special Coverage
Science
Mar 28, 2025, 12:26
Cathy Eng: The Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer
Blog
Mar 28, 2025, 12:15
Recent advancements for treating kidney cancer with Society for Immunotherapy of Cancer’s virtual advances in Cancer Immunotherapy
Blog
Mar 28, 2025, 12:13
Did you hear about CPMS 2.0.? - SIOP Europe
Blog
Mar 28, 2025, 12:06
Sebastian Szmit: Our efforts to develop supportive care in the Polish Society of Clinical Oncology
Blog
Mar 28, 2025, 11:56
Nathan Pennell: The 2025 ASCO Educational Book paper from the Annual Meeting
Dialogues
Mar 28, 2025, 11:31
Episode 4 with Angelo Pirozzi – Cancer Through My Eyes
Blog
Mar 28, 2025, 11:30
Joel Helmke: The role Houston plays in advancing medicine
Blog
Mar 28, 2025, 11:28
Aydah AlAwadhi: The UAE National Cancer Registry report for 2023
Blog
Mar 28, 2025, 11:26
In Memoriam Petra Peeters - Julius Center Research Program Cancer
Blog
Mar 28, 2025, 11:15
Edward Cliff: All things post-CAR-T malignancies on Blood Cancer Talks
Oncolibrary
Mar 28, 2025, 11:09
FDA approval: Cabozantinib was approved for unresectable, locally advanced or metastatic well-differentiated pNET and well-differentiated epNET
Blog
Mar 28, 2025, 11:07
What health policies do you think we should develop? - ASCO